Journal article · 2026

Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases

Haonan Feng, Yichao Kong, Peng Tang, Haoxin Huang, Yutong Li, Wenjing Gu, Yaxia Yuan, Lei Fang, Weiwei Huang, Xiabin Chen, Lei Ma

Journal of Medicinal Chemistry · Published 7 November 2026 · DOI 10.1021/acs.jmedchem.6c02821

View at the publisherCite this paper

In brief

“Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases” is a 2026 journal article by Haonan Feng and 10 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 0 citations as of 16 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
References
50
Authors
11

Abstract

Persistent NLRP3 activation drives chronic inflammatory diseases, necessitating inhibitors with sustained exposure and tolerability. Rational optimization of the hydrophobic and solvent-exposed regions of MCC950 yielded sulfonylurea F34, which inhibited NLRP3-dependent IL-1β release (IC50 = 38.81 nM), with nanomolar potency similar to MCC950, without apparent NLRC4 or AIM2 inhibition. Docking predicted that F34 binds within the… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Feng, H., Kong, Y., Tang, P., Huang, H., Li, Y., Gu, W., Yuan, Y., Fang, L., Huang, W., Chen, X., & Ma, L. (2026). Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02821

MLA 9

Feng, Haonan, et al. “Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases.” Journal of Medicinal Chemistry, 2026. https://doi.org/10.1021/acs.jmedchem.6c02821.

Chicago

Feng, Haonan, Yichao Kong, Peng Tang, Haoxin Huang, Yutong Li, Wenjing Gu, Yaxia Yuan, et al. 2026. “Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases.” Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02821.

Harvard

Feng, H. et al. (2026) ‘Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases’, Journal of Medicinal Chemistry. doi:10.1021/acs.jmedchem.6c02821.

IEEE

H. Feng et al., “Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases,” Journal of Medicinal Chemistry, 2026, doi: 10.1021/acs.jmedchem.6c02821.

BibTeX

@article{feng2026design,
  title     = {{Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases}},
  author    = {Feng, Haonan and Kong, Yichao and Tang, Peng and Huang, Haoxin and Li, Yutong and Gu, Wenjing and Yuan, Yaxia and Fang, Lei and Huang, Weiwei and Chen, Xiabin and Ma, Lei},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  doi       = {10.1021/acs.jmedchem.6c02821},
  url       = {https://doi.org/10.1021/acs.jmedchem.6c02821}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders

  • NLRP3 inhibitors
  • MCC950
  • sulfonylurea derivatives
  • IL-1β release
  • chronic inflammatory diseases
  • gout
  • DSS-induced colitis
  • oral bioavailability

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Feng, H., Kong, Y., Tang, P., Huang, H., Li, Y., Gu, W., Yuan, Y., Fang, L., Huang, W., Chen, X., & Ma, L. (2026). Design, Synthesis, and Evaluation of a Potent NLRP3 Inflammasome Inhibitor with Favorable Pharmacokinetic and Safety Profiles for Chronic Inflammatory Diseases. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c02821

How many times has this paper been cited?

0 times, according to OpenAlex on 16 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Haonan Feng, Yichao Kong, Peng Tang, Haoxin Huang, Yutong Li, Wenjing Gu, Yaxia Yuan, Lei Fang, Weiwei Huang, Xiabin Chen, Lei Ma.

What is the DOI of this paper?

10.1021/acs.jmedchem.6c02821, permanently at https://doi.org/10.1021/acs.jmedchem.6c02821. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 16 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.